SSG
AVNS

Summit Securities Group’s Avanos Medical AVNS Stock Holding History

Summit Securities Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,217
Closed -$49K – 368
2015
Q2 		$49K Buy
+1,217
New +$54.6K 0.02% 186
2015
Q1 		– Sell
-3,569
Closed -$162K – 394
2014
Q4 		$162K Buy
+3,569
New +$140K 0.05% 218

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Summit Securities Group's AVNS Position: Q3 2015 in Review

Summit Securities Group sold out of Avanos Medical (AVNS) in Q3 2015, closing a stake of 1,217 shares — an estimated $49K sold.

Summit Securities Group first reported a position in AVNS in Q4 2014 and held it in 2 quarters. The position peaked at $162K in Q4 2014. 353 funds tracked by Wall St. Rank hold AVNS as of Q3 2015.

  • Summit Securities Group reported no remaining Avanos Medical position as of Q3 2015 after selling out during the quarter.
  • Summit Securities Group sold 1,217 Avanos Medical shares in Q3 2015, an estimated $49K.
  • Summit Securities Group first reported a position in Avanos Medical in Q4 2014 and held it in 2 quarters.
  • Summit Securities Group's Avanos Medical position peaked at $162K in Q4 2014.
  • 353 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2015.

Based on Summit Securities Group's 13F filing for Q3 2015, filed 12 Nov 2015.